← 返回前沿论文

整合单细胞和空间转录组分析鉴定 LMX1B 作为肾细胞癌中调控 GDF15-ATP4B 轴的抑癌因子

英文原题:Integrative single-cell and spatial transcriptomic analyses identify LMX1B as a tumor suppressor orchestrating the GDF15-ATP4B axis in renal cell carcinoma.

PubMed 2026/09/18(内容时间) Transl Oncol Q2 · IF 4.9(JCR 2025)

研究概要

我们的整合多组学和功能分析确立了LMX1B-GDF15-ATP4B轴是RCC中关键的肿瘤抑制级联。这些发现阐明了发育必需的转录因子如何调控肾脏恶性肿瘤中的TME组织和线粒体稳态,并将LMX1B确定为RCC有前景的预后生物标志物和治疗靶点。

研究思路结论见上方概要

肾细胞癌(RCC)以显著的瘤间和瘤内异质性以及广泛的肿瘤微环境(TME)重塑为特征,然而,驱动恶性进展的空间分辨细胞程序及细胞间通讯网络仍鲜有明确。LMX1B 是一种对肾脏形态发生至关重要的 LIM 同源域转录因子,此前尚未在肾癌发生中被研究过。

我们整合了三个独立RCC队列的单细胞RNA测序(scRNA-seq)和空间转录组学(ST),并辅以分层差异加权基因共表达网络分析(hdWGCNA)、基于CellChat的配体-受体相互作用分析、RCTD空间解卷积和mistyR共定位分析。多平台验证包括qRT-PCR、western blot、TCGA和CCLE数据库挖掘、染色质免疫沉淀、双荧光素酶报告基因检测,以及体外和皮下异种移植模型中的功能研究。

ScRNA-seq和ST分析揭示,LMX1B主要表达于上皮细胞,并且与正常对应细胞相比,在肿瘤来源的上皮细胞群体中显著下调,其表达降低与晚期肿瘤分级和淋巴转移相关。LMX1B相关上皮细胞(LMX1B-Epi)作为TME内的中心信号枢纽,通过VEGFA、SPP1和GDF15介导的通路与成纤维细胞、内皮细胞、髓系细胞和T/NK细胞进行广泛的双向通讯。空间解卷积表明,LMX1B-Epi占据不同于LMX1B阴性上皮细胞的特化组织生态位。HdWGCNA鉴定出五个共表达模块,富集于应激反应、代谢和线粒体ATP合成,所有这些模块在正常与肿瘤LMX1B-Epi之间均表现出显著的差异激活。在功能上,LMX1B过表达抑制RCC细胞增殖、迁移和侵袭。在机制上,LMX1B直接结合GDF15启动子以转录激活其表达。GDF15反过来正向调控ATP4B,并通过ROS介导的线粒体膜电位去极化和Bax/Bcl-2-caspase-3级联激活诱导线粒体凋亡。挽救实验证实,ATP4B过表达在体外和体内均逆转GDF15敲低的致癌效应。

展开英文摘要原文

BACKGROUND: Renal cell carcinoma (RCC) is characterized by profound inter- and intratumoral heterogeneity and extensive tumor microenvironment (TME) remodeling, yet the spatially resolved cellular programs and intercellular communication networks orchestrating malignant progression remain poorly defined. LMX1B, a LIM homeodomain transcription factor essential for kidney morphogenesis, has not been previously investigated in renal carcinogenesis. METHODS: We integrated single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics (ST) across three independent RCC cohorts, complemented by hierarchical differential weighted gene co-expression network analysis (hdWGCNA), CellChat-based ligand-receptor interaction analysis, RCTD spatial deconvolution, and mistyR colocalization analysis. Multi-platform validation included qRT-PCR, western blot, TCGA and CCLE database mining, chromatin immunoprecipitation, dual-luciferase reporter assays, and functional studies in vitro and in subcutaneous xenograft models. RESULTS: ScRNA-seq and ST analyses revealed that LMX1B is predominantly expressed in epithelial cells and is markedly downregulated in tumor-derived epithelial populations compared to normal counterparts, with reduced expression correlating with advanced tumor grade and lymphatic metastasis. LMX1B-associated epithelial cells (LMX1B-Epi) function as central signaling hubs within the TME, engaging in extensive bidirectional communication with fibroblasts, endothelial cells, myeloid cells, and T/NK cells through VEGFA-, SPP1-, and GDF15-mediated pathways. Spatial deconvolution demonstrated that LMX1B-Epi occupy specialized tissue niches distinct from LMX1B-negative epithelial cells. HdWGCNA identified five co-expression modules enriched for stress response, metabolism, and mitochondrial ATP synthesis, all exhibiting significant differential activation between normal and tumor LMX1B-Epi. Functionally, LMX1B overexpression suppressed RCC cell proliferation, migration, and invasion. Mechanistically, LMX1B directly binds to the GDF15 promoter to transcriptionally activate its expression. GDF15, in turn, positively regulates ATP4B and induces mitochondrial apoptosis through ROS-mediated mitochondrial membrane potential depolarization and Bax/Bcl-2-caspase-3 cascade activation. Rescue experiments confirmed that ATP4B overexpression reverses the oncogenic effects of GDF15 knockdown both in vitro and in vivo. CONCLUSIONS: Our integrative multi-omic and functional analyses establish the LMX1B-GDF15-ATP4B axis as a critical tumor-suppressive cascade in RCC. These findings illuminate how a developmentally essential transcription factor governs TME organization and mitochondrial homeostasis in renal malignancy, and identify LMX1B as a promising prognostic biomarker and therapeutic target for RCC.

论文信息

作者
Liu Y、Song L、Feng Y、Zhang S、Han X、Tan Y、Li N、Wang Y
第一作者单位
Department of Urology, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Zhengzhou, Henan, 450052, China.China
通讯作者单位
Department of Urology, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Zhengzhou, Henan, 450052, China. Electronic address: yangjinjian2011@126.com.China
期刊
Translational oncology2026 Sep 18
原文标识
PubMed 42759406 · DOI 10.1016/j.tranon.2026.103049